Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0064 | 0.703 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0064 | 0.703 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0064 | 0.703 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0064 | 0.703 | 0.5 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0064 | 0.703 | 0.5 |
Loa Loa (eye worm) | brahma associated protein | 0.0064 | 0.703 | 0.5 |
Chlamydia trachomatis | SWIB complex protein | 0.0064 | 0.703 | 0.5 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0064 | 0.703 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0064 | 0.703 | 0.5 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0064 | 0.703 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0064 | 0.703 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0064 | 0.703 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0064 | 0.703 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0064 | 0.703 | 0.5 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0064 | 0.703 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0064 | 0.703 | 0.5 |
Onchocerca volvulus | 0.0064 | 0.703 | 0.5 | |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0064 | 0.703 | 0.5 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0064 | 0.703 | 0.5 |
Trypanosoma brucei | RNA helicase, putative | 0.0081 | 1 | 1 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0064 | 0.703 | 0.5 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0064 | 0.703 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | 0 | Inhibition of T-type calcium channel Cav3.1 with alpha1G subunit expressed in HEK293 cells at 100 uM by FDSS6000 assay | ChEMBL. | 17035033 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.